European Medicines Agency ' s Committee for Medicinal Products for Human Use recommends booster dose of Moderna ' s COVID-19 vaccine, Spikevax , EMA

This follows data showing that a booster, consisting of half the dose used for primary vaccination, given 6 to 8 months after 2nd dose, led to a rise in antibody levels in adults whose antibody levels were waning, with a pattern of side effects similar to that after 2nd dose.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news